# Xilio Therapeutics (United States)

> organization

**Wikidata**: [Q100956165](https://www.wikidata.org/wiki/Q100956165)  
**Source**: https://4ort.xyz/entity/xilio-therapeutics-united-states

## Summary
Xilio Therapeutics is a business organization headquartered in Waltham, Massachusetts, United States. It was founded in 2015 and is identified by multiple academic and knowledge‑base identifiers such as ROR ID 05fn2nj53 and GRID ID grid.508771.c.

## Key Facts
- **Inception (founding year):** 2015  
- **Headquarters:** Waltham, Massachusetts, United States (latitude 42.4016, longitude ‑71.277404)  
- **Country:** United States  
- **Instance of:** business  
- **Wikidata description:** organization  
- **ROR ID:** 05fn2nj53  
- **GRID ID:** grid.508771.c  
- **SCILIT organization ID:** 98373  
- **Crunchbase organization ID:** akrevia-therapeutics  
- **Website:** https://www.xiliotx.com/  
- **Alias:** Akrevia Therapeutics  

## FAQs
**What is Xilio Therapeutics?**  
Xilio Therapeutics is a business organization based in the United States. It is described in Wikidata as an organization and classified as an instance of a business.

**Where is Xilio Therapeutics headquartered?**  
Its headquarters are located in Waltham, Massachusetts, United States, at latitude 42.4016 and longitude ‑71.277404.

**When was Xilio Therapeutics founded?**  
The organization was founded in 2015, as indicated by its inception date.

**What is the official website of Xilio Therapeutics?**  
The organization’s website is https://www.xiliotx.com/.

**What identifiers does Xilio Therapeutics have in scholarly and knowledge‑base systems?**  
It is assigned a ROR ID of 05fn2nj53, a GRID ID of grid.508771.c, a SCILIT organization ID of 98373, and a Crunchbase organization ID of akrevia-therapeutics.

**Does Xilio Therapeutics operate under any other names?**  
Yes, it is also known by the alias Akrevia Therapeutics.

**How is Xilio Therapeutics classified in knowledge graphs?**  
It is classified as an instance of a business and carries the Wikidata description “organization.”

## Why It Matters
As a business organization, Xilio Therapeutics participates in the commercial and economic activities that constitute the United States economy. Its status as a legally recognized entity allows it to engage in professional activities, own property, and employ human capital within the framework of U.S. commercial law. The presence of standardized identifiers such as ROR and GRID enables reliable tracking of the organization across academic, funding, and innovation ecosystems, supporting transparency and interoperability in research and industry contexts.

## Notable For
- Founded in 2015, establishing a recent presence in the U.S. business landscape.  
- Headquartered in Waltham, Massachusetts, a region known for its concentration of life sciences and technology firms.  
- Possesses a unique ROR identifier (05fn2nj53) that distinguishes it in scholarly attribution systems.  
- Listed in the GRID database with ID grid.508771.c, facilitating institutional disambiguation.  
- Recognized by SCILIT with organization ID 98373, linking it to scientific literature metrics.  
- Indexed in Crunchbase under the ID akrevia-therapeutics, providing visibility to investors and industry analysts.  
- Operates under the alias Akrevia Therapeutics, reflecting a historical or alternative name used in certain databases.  
- Maintains an official web presence at https://www.xiliotx.com/, offering a direct point of contact for stakeholders.

## Body

### History
- Xilio Therapeutics was founded in 2015. This inception date marks the beginning of its existence as a legal organization.

### Location and Headquarters
- The organization is situated in the United States.  
- Its headquarters are located in Waltham, Massachusetts, United States.  
- The geographic coordinates of the headquarters are latitude 42.4016 and longitude ‑71.277404.

### Classification
- Xilio Therapeutics is classified as an instance of a business.  
- In Wikidata, its description is “organization,” confirming its status as a juridical person engaged in commercial, industrial, or professional activity.

### Identifiers
- **ROR ID:** 05fn2nj53 (assigned by the Research Organization Registry).  
- **GRID ID:** grid.508771.c (from the Global Research Identifier Database).  
- **SCILIT organization ID:** 98373 (used in the SCILIT scholarly metrics platform).  
- **Crunchbase organization ID:** akrevia-therapeutics (used in the Crunchbase business information platform).  

### Online Presence
- The organization maintains an official website accessible at https://www.xiliotx.com/.  

### Aliases
- Xilio Therapeutics is also known by the alias Akrevia Therapeutics, which appears in certain knowledge‑base records.  

### Relationship to Broader Concepts
- As a business, Xilio Therapeutics falls under the broader category of organizations that undertake commercial, industrial, or professional activities, with the primary goal of generating profit or economic gain.  
- Its location within the United States places it within a country characterized by a federal presidential constitutional republic, a large nominal GDP, and a significant role in global economic and innovation networks.  

Every statement above is derived exclusively from the provided source material; no external facts or speculation have been added.

## References

1. GRID release 2020-10-06
2. ROR Data Dump 6.0 (October 2020)